Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly

被引:53
作者
Epaminonda, P [1 ]
Porretti, S [1 ]
Cappiello, V [1 ]
Beck-Peccoz, P [1 ]
Faglia, G [1 ]
Arosio, M [1 ]
机构
[1] Univ Milan, Osped Maggiore, IRCCS, Inst Endocrine Sci, I-20122 Milan, Italy
关键词
D O I
10.1046/j.1365-2265.2001.01294.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Radiotherapy (RT) has been used for many years in order to complete the cure of unsuccessfully operated acromegalic patients. Several studies have shown its efficacy in normalizing GH levels, while reports about IGF-I normalization are conflicting. Moreover, data regarding other markers of disease activity, such as IGFBP-3 and acid-labile subunit (ALS), i.e. the other two components of the circulating 150 kDa complex, are lacking. DESIGN Retrospective study. PATIENTS AND MEASUREMENTS Sixty-seven acromegalic patients (20 males and 47 females, aged 40 +/- 6 years) who underwent postoperative FIT (in fractionated doses for a total of 40-75 Gy) were followed-up for 11 +/- 6 years (range: 1-26 years, median: 10 years). Serum GH and IGF-I levels off medical therapy were measured in all patients; ALS and IGFBP-3 were measured in 11 patients with normalization of IGF-I concentrations. Computed tomography or nuclear magnetic resonance imaging periodically assessed possible development of pituitary deficiency along with imaging of the hypothalamic-pituitary region. RESULTS Forty-one out of 67 patients (58%) achieved GH levels <2.5 <mu>g/l by 1-15 years after FIT (mean 8 +/- 6) and 37/67 patients (55%) had normal or low IGF-I levels 1-26 years after RT (mean: 12 +/- 6), a normalization of both parameters being seen in 37 patients. GH <2.5 <mu>g/l and normal IGF-I levels were achieved in 17/26 (65%) patients followed-up for at least 15 years. ALS and IGFBP-3 concentrations paralleled IGF-I levels in all patients studied. With respect to secondary pituitary insufficiency, acquired ACTH deficiency was found in 25 patients, TSH deficiency in 20, gonadotropin deficiency in 23 and GH deficiency in seven. In total, two cases of meningioma and one pineal tumour, possibly related to FIT, were seen 9-22 years after RT. CONCLUSIONS RT is an effective, although slow-acting, therapeutic tool for acromegaly, with 'safe' GH levels and normal IGF-I concentrations being achieved in 65% of patients after 15 years. IGF-I levels normalize more slowly than GH levels. Radiotherapy is able to normalize the concentration of all three components of the circulating 150 kDa complex. Checks for loss of pituitary function and appearance of second brain tumours must be carried out life-long.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 30 条
  • [1] AFTRAMPE E, 1991, INT J RADIAT ONCOL, V20, P655
  • [2] An unusual treatment-related complication in a patient with growth hormone-secreting pituitary tumor
    Ahmed, M
    Kanaan, I
    Rifai, A
    Tulbah, A
    Ghannam, N
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) : 2816 - 2820
  • [3] Diagnostic value of the acid-labile subunit in acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3
    Arosio, M
    Garrone, S
    Bruzzi, P
    Faglia, G
    Minuto, F
    Barreca, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) : 1091 - 1098
  • [4] BARCELO B, 1998, PITUITARY TUMORS EPI, P127
  • [5] Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly
    Barkan, AL
    Halasz, I
    Dornfeld, KJ
    Jaffe, CA
    Friberg, RD
    Chandler, WF
    Sandler, HM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) : 3187 - 3191
  • [6] EFFECT OF OCTREOTIDE ON CIRCULATING IGF-I CHROMATOGRAPHIC PROFILE - EVIDENCE FOR AN INHIBITORY-ACTION ON THE FORMATION OF THE 150-KDA TERNARY COMPLEX
    BARRECA, A
    CARIOLA, G
    PONZANI, P
    ARVIGO, M
    FOPPIANI, L
    GIORDANO, G
    MINUTO, F
    [J]. CLINICAL ENDOCRINOLOGY, 1995, 42 (02) : 161 - 167
  • [7] BARRECA AM, 1999, P 81 M END SOC, P400
  • [8] BATES AS, 1993, Q J MED, V86, P293
  • [9] The binding protein's binding protein - Clinical applications of acid-labile subunit (ALS) measurement
    Baxter, RC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 3941 - 3943
  • [10] Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly
    Biermasz, NR
    van Dulken, H
    Roelfsema, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) : 2476 - 2482